www.fgks.org   »   [go: up one dir, main page]
This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2018 1
2019 12
2020 12
2021 13
2022 15
2023 8
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and Treatment.
Pettigrew JA, Novick AM. Pettigrew JA, et al. J Midwifery Womens Health. 2021 Nov;66(6):740-748. doi: 10.1111/jmwh.13283. Epub 2021 Sep 12. J Midwifery Womens Health. 2021. PMID: 34510696 Free PMC article. Review.
Many health care providers do not ask about sexual concerns during routine clinical encounters because of personal discomfort, lack of familiarity with treatment, or the belief that they lack adequate time to address this complex issue. This may be especially true for hypoacti …
Many health care providers do not ask about sexual concerns during routine clinical encounters because of personal discomfort, lack of famil …
Sexual Health in Menopause.
Scavello I, Maseroli E, Di Stasi V, Vignozzi L. Scavello I, et al. Medicina (Kaunas). 2019 Sep 2;55(9):559. doi: 10.3390/medicina55090559. Medicina (Kaunas). 2019. PMID: 31480774 Free PMC article. Review.
Androgen Therapy in Women.
Vegunta S, Kling JM, Kapoor E. Vegunta S, et al. J Womens Health (Larchmt). 2020 Jan;29(1):57-64. doi: 10.1089/jwh.2018.7494. Epub 2019 Nov 5. J Womens Health (Larchmt). 2020. PMID: 31687883 Review.
Testosterone, the primary ovarian androgen, has been used to treat carefully selected postmenopausal women with hypoactive sexual desire disorder (HSDD). However, testosterone use in women has not been approved by the United States Food and Drug Admini …
Testosterone, the primary ovarian androgen, has been used to treat carefully selected postmenopausal women with hypoactive sexual …
Female Sexual Dysfunction.
Clayton AH, Valladares Juarez EM. Clayton AH, et al. Med Clin North Am. 2019 Jul;103(4):681-698. doi: 10.1016/j.mcna.2019.02.008. Med Clin North Am. 2019. PMID: 31078200 Review.
The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review.
Uloko M, Rahman F, Puri LI, Rubin RS. Uloko M, et al. Int J Impot Res. 2022 Nov;34(7):635-641. doi: 10.1038/s41443-022-00613-0. Epub 2022 Oct 5. Int J Impot Res. 2022. PMID: 36198811 Free PMC article. Review.
As a result, many postmenopausal women experience Female Sexual Dysfunction (FSD) which are a group of disorders that pertain to sexual arousal, desire, orgasm, and pain. A prevalent manifestation of FSD is Hypoactive Sexual Desire Disorder (HSDD) or t …
As a result, many postmenopausal women experience Female Sexual Dysfunction (FSD) which are a group of disorders that pertain to sexual arou …
Medical Treatment of Female Sexual Dysfunction.
Nappi RE, Tiranini L, Martini E, Bosoni D, Righi A, Cucinella L. Nappi RE, et al. Urol Clin North Am. 2022 May;49(2):299-307. doi: 10.1016/j.ucl.2022.02.001. Urol Clin North Am. 2022. PMID: 35428435 Review.
Flibanserin and bremelanotide are psychoactive agents indicated for the treatment of generalized acquired hypoactive sexual desire disorder (HSDD) in premenopausal women, whereas transdermal testosterone is effective on HSDD in postmenopausal women. .. …
Flibanserin and bremelanotide are psychoactive agents indicated for the treatment of generalized acquired hypoactive sexual …
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ, Simon JA, Davis SR, Giraldi A, Goldstein I, Goldstein SW, Kim NN, Kingsberg SA, Morgentaler A, Nappi RE, Park K, Stuenkel CA, Traish AM, Vignozzi L. Parish SJ, et al. J Sex Med. 2021 May;18(5):849-867. doi: 10.1016/j.jsxm.2020.10.009. Epub 2021 Apr 1. J Sex Med. 2021. PMID: 33814355 Free article. Review.
BACKGROUND: The Global Consensus Position Statement on the Use of Testosterone Therapy for Women (Global Position Statement) recommended testosterone therapy for postmenopausal women with hypoactive sexual desire disorder (HSDD). AIM: To provide a clin …
BACKGROUND: The Global Consensus Position Statement on the Use of Testosterone Therapy for Women (Global Position Statement) recommended tes …
Bremelanotide.
[No authors listed] [No authors listed] 2021 Aug 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2021 Aug 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 34436837 Free Books & Documents. Review.
Bremelanotide is a parenterally administered melanocortin receptor agonist that is used to treat female hypoactive sexual desire disorder. Bremelanotide has been reported to cause mild serum enzyme elevations during therapy and has been implicated in r …
Bremelanotide is a parenterally administered melanocortin receptor agonist that is used to treat female hypoactive sexual d …
Sexual Performance Anxiety.
Pyke RE. Pyke RE. Sex Med Rev. 2020 Apr;8(2):183-190. doi: 10.1016/j.sxmr.2019.07.001. Epub 2019 Aug 22. Sex Med Rev. 2020. PMID: 31447414 Review.
Understanding Hypoactive Sexual Desire Disorder (HSDD) in Women: Etiology, Diagnosis, and Treatment.
Ronghe V, Pannase K, Gomase KP, Mahakalkar MG. Ronghe V, et al. Cureus. 2023 Nov 30;15(11):e49690. doi: 10.7759/cureus.49690. eCollection 2023 Nov. Cureus. 2023. PMID: 38161863 Free PMC article. Review.
Hypoactive Sexual Desire Disorder (HSDD) is a complex and multifaceted condition that significantly impacts the sexual well-being and overall quality of life of women. ...
Hypoactive Sexual Desire Disorder (HSDD) is a complex and multifaceted condition that significantly impacts the …
54 results